| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 53123-88-9 | 雷帕霉素 | Rapamycin; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; SiroLimus |  | C51H79NO13 | 詳情 | 供應(yīng)商 |
| 104987-11-3 | 他克莫司 | TacroLimus; TacroLimus |  | C44H69NO12 | 詳情 | 供應(yīng)商 |
| 137071-32-0 | 吡美莫司; 匹美克莫司 | PimecroLimus; 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[2-(4-chloro-3-methoxycyclohexyl)-1-methylethenyl]-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-,[3S-[3R*[E(1S*,3S*,4R*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-; (-)-PimecroLimus; 33-Epichloro-33-desoxyascomycin; 33-epi-Chloro-33-desoxyascomycin; ASM 981; Elidel; PicroLimus; SDZ-ASM 981; |  | C43H68ClNO11 | 詳情 | 供應(yīng)商 |
| 159351-69-6 | 依維莫司 | EveroLimus; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.; 40-O-(2-Hydroxyethyl)rapamycin; 42-O-(2-Hydroxy)ethylrapamycin; Certican; EveroLimus; RAD; RAD 001; SDZ-RAD; XIENCE V |  | C53H83NO14 | 詳情 | 供應(yīng)商 |
| 162635-04-3 | 西羅莫司脂化物; 雷帕霉素42-[3-羥基-2-(羥甲基)-2-甲基丙酸酯 | TemsiroLimus; Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate |  | C56H87NO16 | 詳情 | 供應(yīng)商 |
| 697252-87-2 | Rapamycin,42-(dimethylphosphinate) (9CI); AP 23573; MK 8669; RidaforoLimus |  | C53H84NO14P | 詳情 | 供應(yīng)商 | |
| 221877-54-9 | Rapamycin,42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-; 42-(1-Tetrazolyl)rapamycin; A 179578; ABT 578; ZotaroLimus |  | C52H79N5O12 | 詳情 | 供應(yīng)商 | |
| 109581-93-3 | 他克莫司; 他克莫司水合物 | TacroLimus; 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,monohydrate, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- (9CI); 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,monohydrate,[3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-; Tsukubaenolide hydrate; |  | C44H69NO12.H2O | 詳情 | 供應(yīng)商 |
| 115308-98-0 | 他莫司汀 | TalLimustine; TalLimustine; FCE-24517; N-[5-[[(3-Amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[4-[bis(2-chloroethyl)amino]benzoylamino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide; TaLimustine |  | C32H38Cl2N10O4 | 詳情 | 供應(yīng)商 |
| 162635-03-2 | TemsiroLimus Acetonide; Rapamycin 42-(2,2,5-Trimethyl-1,3-dioxane-5-carboxylate); TemsiroLimus Acetonide |  | C59H91NO16 | 詳情 | 供應(yīng)商 |